Research reference only. Not medical advice. Most compounds are not FDA-approved. Consult a qualified clinician before any human use.

Tissue Repair & Healing

LL-37

Cathelicidin; hCAP-18 C-terminus

Classification: Cathelicidin antimicrobial peptide; host-defense

Mechanism: Cationic amphipathic α-helix disrupts microbial membranes; modulates host immune response

Benefits: Broad-spectrum antimicrobial; wound healing; biofilm disruption; immune modulation

Evidence tier: Preclinical + Animal Studies · Availability: Research

Primary sources

  1. Bandurska K et al. Unique features of human cathelicidin LL-37. Biofactors 2015. PMID 26434733
  2. Xhindoli D et al. The human cathelicidin LL-37 — a pore-forming antibacterial peptide and host-cell modulator. Biochim Biophys Acta 2016. PMID 26556394

Loading interactive view…